Wells Fargo’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110M | Buy |
142,021
+1,972
| +1% | +$1.51M | 0.02% | 597 |
|
|
2025
Q4 | $108M | Buy |
140,049
+5,829
| +4% | +$3.96M | 0.02% | 596 |
|
|
2025
Q3 | $75.5M | Buy |
134,220
+168
| +0.1% | +$95K | 0.01% | 719 |
|
|
2025
Q2 | $70.4M | Sell |
134,052
-11,634
| -8% | -$6.49M | 0.01% | 710 |
|
|
2025
Q1 | $92.4M | Sell |
145,686
-6,822
| -4% | -$4.69M | 0.02% | 570 |
|
|
2024
Q4 | $109M | Sell |
152,508
-21,533
| -12% | -$18.1M | 0.02% | 511 |
|
|
2024
Q3 | $183M | Buy |
174,041
+17,505
| +11% | +$19.5M | 0.04% | 350 |
|
|
2024
Q2 | $165M | Buy |
156,536
+29,818
| +24% | +$28.9M | 0.04% | 354 |
|
|
2024
Q1 | $122M | Buy |
126,718
+8,284
| +7% | +$7.88M | 0.03% | 427 |
|
|
2023
Q4 | $104M | Buy |
118,434
+1,870
| +2% | +$1.54M | 0.03% | 470 |
|
|
2023
Q3 | $95.9M | Sell |
116,564
-24,171
| -17% | -$19M | 0.03% | 446 |
|
|
2023
Q2 | $101M | Sell |
140,735
-5,872
| -4% | -$4.53M | 0.03% | 443 |
|
|
2023
Q1 | $120M | Sell |
146,607
-10,370
| -7% | -$7.82M | 0.03% | 384 |
|
|
2022
Q4 | $113M | Sell |
156,977
-14,152
| -8% | -$10.4M | 0.03% | 393 |
|
|
2022
Q3 | $118M | Sell |
171,129
-27,969
| -14% | -$17.6M | 0.04% | 351 |
|
|
2022
Q2 | $118M | Sell |
199,098
-29,212
| -13% | -$19M | 0.04% | 371 |
|
|
2022
Q1 | $159M | Buy |
228,310
+26,495
| +13% | +$16.8M | 0.04% | 343 |
|
|
2021
Q4 | $127M | Sell |
201,815
-67,766
| -25% | -$41.7M | 0.03% | 399 |
|
|
2021
Q3 | $163M | Sell |
269,581
-890
| -0.3% | -$553K | 0.04% | 460 |
|
|
2021
Q2 | $151M | Buy |
270,471
+2,008
| +0.7% | +$1.02M | 0.03% | 485 |
|
|
2021
Q1 | $127M | Sell |
268,463
-61,198
| -19% | -$29.8M | 0.03% | 554 |
|
|
2020
Q4 | $159M | Sell |
329,661
-30,323
| -8% | -$16.4M | 0.04% | 456 |
|
|
2020
Q3 | $202M | Buy |
359,984
+50,493
| +16% | +$30.6M | 0.06% | 329 |
|
|
2020
Q2 | $193M | Buy |
309,491
+85,885
| +38% | +$48.7M | 0.06% | 321 |
|
|
2020
Q1 | $109M | Buy |
223,606
+33,611
| +18% | +$13.9M | 0.04% | 438 |
|
|
2019
Q4 | $71.3M | Sell |
189,995
-1,635
| -0.9% | -$550K | 0.02% | 745 |
|
|
2019
Q3 | $53.2M | Sell |
191,630
-6,354
| -3% | -$1.88M | 0.02% | 882 |
|
|
2019
Q2 | $62M | Sell |
197,984
-116,084
| -37% | -$38.6M | 0.02% | 815 |
|
|
2019
Q1 | $129M | Buy |
314,068
+53,291
| +20% | +$21.9M | 0.04% | 454 |
|
|
2018
Q4 | $97.4M | Buy |
260,777
+65,331
| +33% | +$23.9M | 0.03% | 523 |
|
|
2018
Q3 | $79M | Sell |
195,446
-42,427
| -18% | -$16.1M | 0.02% | 693 |
|
|
2018
Q2 | $82.1M | Buy |
237,873
+12,269
| +5% | +$3.84M | 0.02% | 661 |
|
|
2018
Q1 | $77.7M | Sell |
225,604
-285
| -0.1% | -$99.1K | 0.02% | 685 |
|
|
2017
Q4 | $84.9M | Sell |
225,889
-29,015
| -11% | -$11.8M | 0.02% | 644 |
|
|
2017
Q3 | $114M | Sell |
254,904
-131,017
| -34% | -$62.3M | 0.04% | 502 |
|
|
2017
Q2 | $190M | Sell |
385,921
-34,453
| -8% | -$15.1M | 0.06% | 324 |
|
|
2017
Q1 | $163M | Sell |
420,374
-236,803
| -36% | -$87.8M | 0.05% | 361 |
|
|
2016
Q4 | $241M | Buy |
657,177
+36,597
| +6% | +$13.9M | 0.09% | 239 |
|
|
2016
Q3 | $249M | Sell |
620,580
-5,817
| -0.9% | -$2.33M | 0.09% | 235 |
|
|
2016
Q2 | $219M | Sell |
626,397
-75,498
| -11% | -$29.1M | 0.08% | 253 |
|
|
2016
Q1 | $253M | Sell |
701,895
-297,191
| -30% | -$122M | 0.1% | 225 |
|
|
2015
Q4 | $542M | Sell |
999,086
-135,110
| -12% | -$73.2M | 0.21% | 102 |
|
|
2015
Q3 | $528M | Sell |
1,134,196
-3,328
| -0.3% | -$1.79M | 0.22% | 97 |
|
|
2015
Q2 | $580M | Sell |
1,137,524
-33,710
| -3% | -$16.5M | 0.22% | 96 |
|
|
2015
Q1 | $529M | Sell |
1,171,234
-106,202
| -8% | -$45M | 0.21% | 112 |
|
|
2014
Q4 | $524M | Sell |
1,277,436
-200,115
| -14% | -$78.7M | 0.21% | 110 |
|
|
2014
Q3 | $533M | Sell |
1,477,551
-173,775
| -11% | -$58.2M | 0.22% | 98 |
|
|
2014
Q2 | $466M | Buy |
1,651,326
+41,662
| +3% | +$12.3M | 0.19% | 124 |
|
|
2014
Q1 | $483M | Buy |
1,609,664
+655,109
| +69% | +$202M | 0.21% | 114 |
|
|
2013
Q4 | $263M | Buy |
954,555
+320,066
| +50% | +$92.1M | 0.11% | 225 |
|
|
2013
Q3 | $199M | Buy |
634,489
+242,580
| +62% | +$63.8M | 0.09% | 264 |
|
|
2013
Q2 | $88.1M | Buy |
+391,909
| New | +$91.3M | 0.05% | 435 |
|
Other funds holding REGN
VCM
N
Wells Fargo's REGN Position: Q1 2026 in Review
Wells Fargo increased its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q1 2026, buying an estimated $1.51M and bringing the position to 142,021 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #597.
Wells Fargo first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $580M in Q2 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Wells Fargo held 142,021 shares of Regeneron Pharmaceuticals worth $110M as of Q1 2026.
- Wells Fargo bought 1,972 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.51M.
- Regeneron Pharmaceuticals made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #597 holding.
- Wells Fargo first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Regeneron Pharmaceuticals position peaked at $580M in Q2 2015.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.